114 related articles for article (PubMed ID: 3495509)
1. Hypoxia-selective radiosensitization of mammalian cells by nitracrine, an electron-affinic DNA intercalator.
Roberts PB; Anderson RF; Wilson WR
Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Apr; 51(4):641-54. PubMed ID: 3495509
[TBL] [Abstract][Full Text] [Related]
2. 5-Nitro-4-(N,N-dimethylaminopropylamino)quinoline (5-nitraquine), a new DNA-affinic hypoxic cell radiosensitizer and bioreductive agent: comparison with nitracrine.
Wilson WR; Siim BG; Denny WA; van Zijl PL; Taylor ML; Chambers DM; Roberts PB
Radiat Res; 1992 Sep; 131(3):257-65. PubMed ID: 1438685
[TBL] [Abstract][Full Text] [Related]
3. Radiosensitization of mammalian cells in vitro by nitroacridines.
Roberts PB; Denny WA; Wakelin LP; Anderson RF; Wilson WR
Radiat Res; 1990 Aug; 123(2):153-64. PubMed ID: 2389001
[TBL] [Abstract][Full Text] [Related]
4. Correlation of the radiosensitization potency afforded by nitroacridine intercalators with their electron scavenging efficiency in DNA.
Anderson RF; Denny WA; Roberts PB; Wardman P; White J; Wilson WR
Int J Radiat Oncol Biol Phys; 1992; 22(3):537-40. PubMed ID: 1735692
[TBL] [Abstract][Full Text] [Related]
5. The reaction between nitracrine and glutathione: implications for hypoxic cell radiosensitization and cytotoxicity.
Wilson WR; Anderson RF
Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1001-5. PubMed ID: 2703377
[TBL] [Abstract][Full Text] [Related]
6. Comparison of aromatic and tertiary amine N-oxides of acridine DNA intercalators as bioreductive drugs. Cytotoxicity, DNA binding, cellular uptake, and metabolism.
Siim BG; Hicks KO; Pullen SM; van Zijl PL; Denny WA; Wilson WR
Biochem Pharmacol; 2000 Oct; 60(7):969-78. PubMed ID: 10974206
[TBL] [Abstract][Full Text] [Related]
7. 9-[3-(2-Nitro-1-imidazolyl)propylamino]-1,2,3,4-tetrahydroacridine hydrochloride. A novel DNA-affinic hypoxic cell cytotoxin and radiosensitizer. Comparison with NLA-1.
Papadopoulou MV; Rosenzweig HS; Doddi M; Bloomer WD
Oncol Res; 1994; 6(9):439-48. PubMed ID: 7703530
[TBL] [Abstract][Full Text] [Related]
8. Reductive metabolism and hypoxia-selective toxicity of nitracrine.
Wilson WR; Denny WA; Stewart GM; Fenn A; Probert JC
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1235-8. PubMed ID: 3744944
[TBL] [Abstract][Full Text] [Related]
9. Selective toxicity of nitracrine to hypoxic mammalian cells.
Wilson WR; Denny WA; Twigden SJ; Baguley BC; Probert JC
Br J Cancer; 1984 Feb; 49(2):215-23. PubMed ID: 6696822
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-selective antitumor agents. 2. Electronic effects of 4-substituents on the mechanisms of cytotoxicity and metabolic stability of nitracrine derivatives.
Wilson WR; Thompson LH; Anderson RF; Denny WA
J Med Chem; 1989 Jan; 32(1):31-8. PubMed ID: 2909741
[TBL] [Abstract][Full Text] [Related]
11. Bis-bioreductive agents as hypoxia-selective cytotoxins: nitracrine N-oxide.
Wilson WR; Van Zijl P; Denny WA
Int J Radiat Oncol Biol Phys; 1992; 22(4):693-6. PubMed ID: 1544839
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-selective antitumor agents. 1. Relationships between structure, redox properties and hypoxia-selective cytotoxicity for 4-substituted derivatives of nitracrine.
Wilson WR; Anderson RF; Denny WA
J Med Chem; 1989 Jan; 32(1):23-30. PubMed ID: 2909736
[TBL] [Abstract][Full Text] [Related]
13. NLA-1: a 2-nitroimidazole radiosensitizer targeted to DNA by intercalation.
Denny WA; Roberts PB; Anderson RF; Brown JM; Phil D; Wilson WR
Int J Radiat Oncol Biol Phys; 1992; 22(3):553-6. PubMed ID: 1735695
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-selective antitumor agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracrine N-oxide.
Lee HH; Wilson WR; Ferry DM; van Zijl P; Pullen SM; Denny WA
J Med Chem; 1996 Jun; 39(13):2508-17. PubMed ID: 8691448
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic studies of enhanced in vitro radiosensitization and hypoxic cell cytotoxicity by targeting radiosensitizers to DNA via intercalation.
Cowan DS; Kanagasabapathy VM; McClelland RA; Rauth AM
Int J Radiat Oncol Biol Phys; 1992; 22(3):541-4. PubMed ID: 1735693
[TBL] [Abstract][Full Text] [Related]
16. Radiosensitization by nickel lapachol.
Skov KA; Adomat H; Farrell NP
Int J Radiat Biol; 1993 Dec; 64(6):707-13. PubMed ID: 7903338
[TBL] [Abstract][Full Text] [Related]
17. Radiosensitizers as probes of DNA damage and cell killing.
Greenstock CL; Whitehouse RP
Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Nov; 48(5):701-10. PubMed ID: 3877011
[TBL] [Abstract][Full Text] [Related]
18. Metabolism and radiosensitization of 4,5-dimethylmisonidazole, a ring-substituted analog of misonidazole.
Born JL; Smith BR; Harper N; Koch CJ
Biochem Pharmacol; 1992 Mar; 43(6):1337-44. PubMed ID: 1562284
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo radiosensitization by 2-nitroimidazoles more electron-affinic than misonidazole.
Brown DM; Yu NY; Brown JM; Lee WW
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):435-8. PubMed ID: 7107364
[TBL] [Abstract][Full Text] [Related]
20. Radiosensitization and hypoxic cell toxicity of NLA-1 and NLA-2, two new bioreductive compounds.
Papadopoulou MV; Epperly MW; Shields DS; Bloomer WD
Jpn J Cancer Res; 1992 Apr; 83(4):410-4. PubMed ID: 1506276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
